ArticleMedical image analysis2026
PCa-Mamba: Spatiotemporal state space models for prostate cancer detection in multi-parametric MRI.
Article in Medical image analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Federated continual learning for privacy-preserving chest radiograph classification.Scientific reports · 2026Article
- Prioritising Data Quality Governance for AI in Prostate Cancer: A Methodological Proof-of-Concept Study Using Neural Networks for Risk Stratification.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Multiparametric Magnetic Resonance Imaging (mpMRI), including T2-weighted imaging (T2), diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE) imaging is an important technique for the diagnosis of clinically significant prostate cancer (csPCa). Unlike T2 and DWI, which capture spatial contrast, DCE-MRI captures the temporal dynamics before, during, and after the administration of the contrast agent. The temporal dynamics of DCE-MRI characterize the microvascular properties of target tissue, offering valuable information for csPCa diagnosis. However, due to the high data dimensionality and spatial-temporal data incompatibility, DCE-MRI has been largely overlooked or underutilized in prevalent deep learning-based csPCa detection methods. In this paper, we propose PCa-Mamba, a state-space model (SSM)-based framework that, for the first time, fully incorporates the temporal dynamics of DCE-MRI alongside the spatial contrast of T2 and DWI for csPCa detection in mpMRI. SSMs are efficient for long-range sequence modeling, making them well-suited for high-dimensional, heterogeneous mpMRI data. PCa-Mamba comprises two SSM modules: (i) a temporal SSM that captures the temporal dynamics, and (ii) a spatial SSM that extracts spatial contrast. Pharmacokinetic (PK) regularization is introduced to constrain the temporal SSM with the Tofts model, allowing the model to learn the PK properties of the target tissue while reducing overfitting. Permuted sequentialization is introduced into the spatial SSM to rearrange spatial patches along different scan directions. This enhances spatial context while preserving local adjacency. The spatial and temporal features are jointly optimized by interactive fusion for integrated spatiotemporal representations, effectively capturing the complementary information for csPCa detection. We further introduce a dropout mechanism that randomly excludes DCE-MRI during training, allowing the model to handle practical scenarios where DCE-MRI is unavailable. Extensive experiments on our in-house dataset and the PI-CAI dataset demonstrate PCa-Mamba's superiority over existing models for csPCa detection, as well as the advantages of mpMRI over bpMRI in lesion-wise csPCa diagnosis, especially for detecting small lesions and those located in the peripheral zone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.